Target intelligence / Profile preview

Kruppel like factor 2 pseudogene 4 (KLF2P4)

Target
KLF2P4
Molecular classification
Other (pseudogene)
01

Overview

KLF2P4 is a human pseudogene that shares sequence similarity with Kruppel like factor 2 (KLF2), which is a member of the Kruppel-like factors (KLFs) family of zinc finger transcriptional regulators. Pseudogenes do not encode functional proteins and are generally considered non-functional remnants of duplicated or mutated genes. Kruppel like factor 2 itself is a well-studied transcription factor involved in vascular biology, immune regulation, and cell differentiation, but KLF2P4 does not produce a protein and is not recognized as a therapeutic target or biomarker. There is no evidence in current biomedical databases or the literature indicating any direct biological function, disease association, drug interaction, or therapeutic relevance for KLF2P4. The most relevant research and clinical interest centers on KLF2 and its related functional family members such as KLF4. If information on a therapeutic target is needed, KLF2 (not KLF2P4) is the canonical gene to investigate for roles in vascular inflammation, endothelial function, and related disease mechanisms. No synonyms, aliases, or alternative names for KLF2P4 appear in common biomedical usage beyond its formal gene symbol. This “target” is not a recognized protein, receptor, or therapeutic target; it is a pseudogene, and its inclusion as a drug target is likely incorrect. If you intended to inquire about KLF2 or another KLF family member, please clarify for further information.

Other names
Kruppel-like factor 2 pseudogene 4KLF2P4

Beyond the preview

Go deeper on Kruppel like factor 2 pseudogene 4 (KLF2P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kruppel like factor 2 pseudogene 4 (KLF2P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call